UB Paderborn / Katalog / Suche / in CDI

High-Dose Therapy and Autologous Stem-Cell Transplantation in Angioimmunoblastic Lymphoma : Complete Remission at Transplantation Is the Major Determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Journal of clinical oncology, 2008-01, Vol.26 (2), p.218-224

2008

Volltextzugriff (PDF)

A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony‐stimulating factor: significant effects on quality of life

British journal of haematology, 2003-03, Vol.120 (6), p.1037-1046

2003

Volltextzugriff (PDF)

Negative Effect of DNA Hypermethylation on the Outcome of Intensive Chemotherapy in Older Patients with High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia following Myelodysplastic Syndrome

Clinical cancer research, 2007-12, Vol.13 (23), p.7107-7112

2007

Volltextzugriff (PDF)

Selective priming of peripheral blood eosinophils in patients with idiopathic hypereosinophilic syndrome

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2006-11, Vol.114 (11), p.757-763

2006

Volltextzugriff (PDF)

High-Dose Therapy and Autologous Stem-Cell Transplantation in Angioimmunoblastic Lymphoma: Complete Remission at Transplantation Is the Major Determinant of Outcome—Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Journal of clinical oncology, 2008-01, Vol.26 (2), p.218-224

2008

Volltextzugriff (PDF)

Maintenance treatment with azacytidine for patients with high‐risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy

British journal of haematology, 2010-08, Vol.150 (3), p.293-302

2010

Volltextzugriff (PDF)

Successful repeated treatment with high dose cyclophosphamide and autologous blood stem cell transplantation in CIDP

BMJ case reports, 2009, Vol.2009 (jan27 1), p.bcr0920080927-bcr0920080927

2009

Volltextzugriff (PDF)

Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes

Haematologica (Roma), 2006-05, Vol.91 (5), p.667-670

2006

Volltextzugriff (PDF)

Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: Results from a randomized phase II study and long-term follow-up of 71 patients

Blood, 1998-07, Vol.92 (1), p.68-75

1998

Volltextzugriff (PDF)

Autologous Stem Cell Transplantation (ASCT) for Enteropathy-Associated T-Cell Lymphoma (EATCL): A Retrospective Study of the European Group for Blood and Marrow Transplantation (EBMT)

Blood, 2011-11, Vol.118 (21), p.3115-3115

2011

Volltextzugriff (PDF)

Concomitant invasive pulmonary aspergillosis and aspergillus sinusitis in a patient with acute leukaemia

Acta bio-medica de l'Ateneo Parmense, 2006, Vol.77 Suppl 4 (Suppl 4), p.23-25

2006

Volltextzugriff (PDF)

Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation

23rd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis/12th Annual Conference of Rehabilitation in MS,Prague, Czech Republic,2007-10-11 - 2007-10-14, 2009-02, Vol.15 (2), p.229-237

2009

Volltextzugriff (PDF)

Maintenance Treatment with Azacytidine for Patients with High Risk Myelodysplastic Syndromes or Acute Myeloid Leukaemia in Complete Remission after Intensive Chemotherapy

BLOOD, 2007-11, Vol.110 (11), p.818-818

2007

Volltextzugriff (PDF)

Effect of Busulphan Dose Adjustment on Regimen-Related Toxicity

BLOOD, 2006-11, Vol.108 (11), p.314-314

2006

Volltextzugriff (PDF)

Intensive Treatment and Stem Cell Transplantation in Chronic Myelogenous Leukemia: Long-Term Follow-Up

Acta haematologica, 2005-01, Vol.113 (3), p.155-162

2005

Volltextzugriff (PDF)

Increased Risk for EBV-Lymphoma after Allogeneic Hsct in Adult Lymphoma Patients?A Retrospective Study of Reduced Compared to Myeloablative Conditioning

Blood, 2004-11, Vol.104 (11), p.5116-5116

2004

Volltextzugriff (PDF)

Successful repeated treatment with high dose cyclophosphamide and autologous blood stem cell transplantation in CIDP

Journal of neurology, neurosurgery and psychiatry, 2008-05, Vol.79 (5), p.612-614

2008

Volltextzugriff (PDF)

No benefit of treatment with cyclophosphamide and autologous blood stem cell transplantation in multifocal motor neuropathy

Acta neurologica Scandinavica, 2008-06, Vol.117 (6), p.432-434

2008

Volltextzugriff (PDF)

Hematopoietic stem cell transplantation in MS. Justified, and if so, when?

Läkartidningen, 2006-03, Vol.103 (9), p.640-642

2006

Volltextzugriff (PDF)

Neutrophil granule proteins in cells and serum. Studies during pregnancy and in patients with diabetes and leukemia

Oberg, Gunnar Johan

1986

Volltextzugriff (PDF)

Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction

Scandinavian journal of infectious diseases, 2007, Vol.39 (3), p.235-244

2007

Volltextzugriff (PDF)

Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival

The hematology journal : the official journal of the European Haematology Association, 2004, Vol.5 (6), p.462

2004

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

High-Dose Therapy and Autologous Stem-Cell Transplantation in Angioimmunoblastic Lymphoma : Complete Remission at Transplantation Is the Major Determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony‐stimulating factor: significant effects on quality of life

Negative Effect of DNA Hypermethylation on the Outcome of Intensive Chemotherapy in Older Patients with High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia following Myelodysplastic Syndrome

Selective priming of peripheral blood eosinophils in patients with idiopathic hypereosinophilic syndrome

High-Dose Therapy and Autologous Stem-Cell Transplantation in Angioimmunoblastic Lymphoma: Complete Remission at Transplantation Is the Major Determinant of Outcome—Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Maintenance treatment with azacytidine for patients with high‐risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy

Successful repeated treatment with high dose cyclophosphamide and autologous blood stem cell transplantation in CIDP

Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes

Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: Results from a randomized phase II study and long-term follow-up of 71 patients

Autologous Stem Cell Transplantation (ASCT) for Enteropathy-Associated T-Cell Lymphoma (EATCL): A Retrospective Study of the European Group for Blood and Marrow Transplantation (EBMT)

Concomitant invasive pulmonary aspergillosis and aspergillus sinusitis in a patient with acute leukaemia

Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation

Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndr–ome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy

Maintenance Treatment with Azacytidine for Patients with High Risk Myelodysplastic Syndromes or Acute Myeloid Leukaemia in Complete Remission after Intensive Chemotherapy

Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy + G-CSF in patients with chronic myelogenous leukemia in first chronic phase

Effect of Busulphan Dose Adjustment on Regimen-Related Toxicity

Intensive Treatment and Stem Cell Transplantation in Chronic Myelogenous Leukemia: Long-Term Follow-Up

Increased Risk for EBV-Lymphoma after Allogeneic Hsct in Adult Lymphoma Patients?A Retrospective Study of Reduced Compared to Myeloablative Conditioning

Successful repeated treatment with high dose cyclophosphamide and autologous blood stem cell transplantation in CIDP

Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy plus G-CSF in patients with chronic myelogenous leukemia in first chronic phase

No benefit of treatment with cyclophosphamide and autologous blood stem cell transplantation in multifocal motor neuropathy

Hematopoietic stem cell transplantation in MS. Justified, and if so, when?

Neutrophil granule proteins in cells and serum. Studies during pregnancy and in patients with diabetes and leukemia

Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction

Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival

Suchergebnisse filtern